semaglutide help with weight loss GLP-1 vs Tirzepatide for in Adults How Semaglutide Works to Help

Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes

January 9, 2026: MDLs for Ozempic and other GLP-1 Drugs Grow There are now two separate MDLs for injuries from Ozempic and other GLP-1 drugsone MDL for vision loss caused by NAION and one MDL for other injuries

2 The findings from the OASIS 4 trial, published in the New England Journal of Medicine in September 2025, led the FDA to approve the Wegovy pill in December 2025, making it the first oral GLP-1 medication approved specifically for weight loss

Combination therapy with SGLT2is + GLP-1RAs can address multiple components of the ominous octet (insulin and glucagon secretion, hepatic glucose production, gastrointestinal incretin defect, appetite and weight loss, and muscle and hepatic insulin sensitivity), improve cardiovascular risk, and prevent diabetic nephropathy and should therefore be considered as an option during the early treatment stages of patients with T2DM

Analyses of renal biopsies obtained from T2D patients support a multifactorial pathophysiology as the structural damage observed varies

median age at surgery, 45 years) undergoing metabolic and bariatric surgery at a multidisciplinary weight management center